Amarin Corporation plc (AMRN) Financial Ratios
30 years of historical data (1996–2025) · Healthcare · Biotechnology
EV/EBITDA
N/A
—
5yr avg: 85.75
30Y Low46.4·High85.7
P/FCF
↓
45.77
-3% vs avg
5yr avg: 47.24
30Y Low7.6·High51.5
P/B Ratio
↓
0.67
↓-26% vs avg
5yr avg: 0.91
30Y Low0.4·High26.6
ROE
↓
-8.2%
↓+18% vs avg
5yr avg: -10.0%
30Y Low-316%·High62%
Debt/EBITDA
N/A
—
5yr avg: 0.64
30Y Low0.6·High3.2
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
AMRN Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Amarin Corporation plc currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 45.8x P/FCF, roughly in line with the 5-year average of 47.2x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $309M | $290M | $199M | $355M | $485M | $1.4B | $1.9B | $7.3B | $4.0B | $1.1B | $653M |
| Enterprise Value | $186M | $167M | $86M | $164M | $278M | $1.1B | $1.7B | $6.8B | $3.9B | $1.1B | $671M |
| P/E Ratio → | -8.24 | — | — | — | — | 177.37 | — | — | — | — | — |
| P/S Ratio | 1.44 | 1.36 | 0.87 | 1.16 | 1.31 | 2.33 | 3.04 | 17.09 | 17.65 | 5.99 | 5.02 |
| P/B Ratio | 0.67 | 0.63 | 0.41 | 0.64 | 0.82 | 2.03 | 2.97 | 12.07 | 26.56 | — | — |
| P/FCF | 45.77 | 42.95 | — | 51.53 | — | — | — | — | — | — | — |
| P/OCF | 45.77 | 42.95 | — | 51.35 | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
AMRN EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.78 | 0.38 | 0.53 | 0.75 | 1.96 | 2.75 | 15.73 | 16.91 | 6.26 | 5.16 |
| EV / EBITDA | — | — | — | — | — | 85.75 | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | 100.31 | — | — | — | — | — |
| EV / FCF | — | 24.76 | — | 23.85 | — | — | — | — | — | — | — |
AMRN Profitability
Margins and return-on-capital ratios measuring operating efficiency
Amarin Corporation plc earns an operating margin of -6.5%. Operating margins have expanded from -22.0% to -6.5% over the past 3 years, signaling improving operational efficiency. A negative ROE of -8.2% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 56.6% | 56.6% | 35.6% | 53.9% | 65.7% | 79.2% | 78.6% | 77.7% | 76.2% | 75.2% | 73.6% |
| Operating Margin | -6.5% | -6.5% | -40.2% | -22.0% | -28.7% | 1.8% | -3.2% | -5.6% | -47.2% | -25.2% | -50.4% |
| Net Profit Margin | -18.2% | -18.2% | -35.9% | -19.3% | -28.7% | 1.3% | -2.9% | -5.3% | -50.8% | -37.5% | -66.4% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -8.2% | -8.2% | -15.8% | -10.3% | -16.8% | 1.2% | -2.9% | -6.0% | -267.0% | — | — |
| ROA | -5.7% | -5.7% | -10.8% | -6.9% | -10.8% | 0.8% | -1.9% | -3.6% | -42.6% | -41.3% | -50.7% |
| ROIC | -2.9% | -2.9% | -18.7% | -13.5% | -18.8% | 1.7% | -6.2% | -543.6% | — | — | -551.5% |
| ROCE | -2.8% | -2.8% | -17.0% | -11.3% | -16.0% | 1.5% | -3.0% | -5.6% | -76.9% | -63.4% | -61.5% |
AMRN Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $135M exceeds total debt of $12M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.10 | 0.53 | — | — |
| Debt / EBITDA | — | — | — | — | — | 0.64 | — | — | — | — | — |
| Net Debt / Equity | — | -0.27 | -0.23 | -0.35 | -0.35 | -0.32 | -0.28 | -0.96 | -1.11 | — | — |
| Net Debt / EBITDA | — | — | — | — | — | -15.79 | — | — | — | — | — |
| Debt / FCF | — | -18.19 | — | -27.68 | — | — | — | — | — | — | — |
| Interest Coverage | -5148.71 | -5148.71 | -11027.57 | -6734.75 | -6919.33 | 88.52 | -5.67 | -2.39 | -12.09 | -4.61 | -3.07 |
Net cash position: cash ($135M) exceeds total debt ($12M)
AMRN Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Amarin Corporation plc's current ratio of 3.34x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 2.33x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 2.80x to 3.34x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.34 | 3.34 | 3.31 | 2.80 | 2.66 | 2.37 | 2.86 | 3.53 | 2.40 | 1.41 | 1.92 |
| Quick Ratio | 2.33 | 2.33 | 2.39 | 1.80 | 1.77 | 1.74 | 2.25 | 3.21 | 2.04 | 1.13 | 1.65 |
| Cash Ratio | 1.56 | 1.56 | 1.64 | 1.24 | 1.19 | 1.23 | 1.63 | 2.66 | 1.58 | 0.68 | 1.29 |
| Asset Turnover | — | 0.32 | 0.33 | 0.37 | 0.42 | 0.55 | 0.64 | 0.49 | 0.59 | 1.12 | 0.78 |
| Inventory Turnover | 0.47 | 0.47 | 0.89 | 0.55 | 0.55 | 0.52 | 0.70 | 1.25 | 0.94 | 1.49 | 1.68 |
| Days Sales Outstanding | — | 216.68 | 195.23 | 158.84 | 129.50 | 102.43 | 91.88 | 98.89 | 105.93 | 91.33 | 56.08 |
AMRN Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Amarin Corporation plc does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | 0.6% | — | — | — | — | — |
| FCF Yield | 2.2% | 2.3% | — | 1.9% | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.3% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.3% | 0.0% |
| Shares Outstanding | — | $21M | $21M | $20M | $20M | $20M | $19M | $17M | $15M | $14M | $11M |
Peer Comparison
Compare AMRN with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 AMRNYou | $309M | -8.2 | — | 45.8 | 56.6% | -6.5% | -8.2% | -2.9% | — |
 ELAN | $12B | -51.1 | 16.6 | 42.2 | 43.5% | 5.3% | -3.7% | 1.9% | 4.3 |
 ACAD | $4B | 9.9 | 26.9 | 36.7 | 91.7% | 9.8% | 39.9% | 10.0% | 0.4 |
 SUPN | $3B | -76.9 | 53.4 | 65.5 | 89.6% | -5.1% | -3.7% | -2.8% | 0.7 |
 HRMY | $2B | 11.6 | 5.6 | 5.2 | 77.2% | 24.0% | 20.8% | 42.0% | 1.0 |
 PRGO | $2B | -1.1 | 7.4 | 11.1 | 35.1% | 8.1% | -39.3% | 3.7% | 5.8 |
 PAHC | $2B | 36.3 | 15.7 | 41.8 | 30.9% | 8.5% | 17.8% | 9.8% | 4.9 |
 ABBV | $358B | 85.5 | 15.0 | 20.1 | 70.2% | 32.8% | 6214.7% | 23.9% | 2.4 |
 PFE | $151B | 19.5 | 10.7 | 16.6 | 70.3% | 24.7% | 8.9% | 7.5% | 3.3 |
 AZN | $283B | 27.9 | 15.8 | 24.1 | 81.9% | 23.4% | 22.9% | 14.9% | 1.5 |
 NVO | $203B | 12.7 | 9.4 | 44.7 | 81.0% | 41.3% | 60.7% | 36.2% | 0.9 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 30 years · Updated daily
See AMRN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AMRN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AMRN vs ELAN
Side-by-side business, growth, and profitability comparison vs Elanco Animal Health Incorporated.
Start ComparisonAMRN — Frequently Asked Questions
Quick answers to the most common questions about buying AMRN stock.
What is Amarin Corporation plc's P/E ratio?
Amarin Corporation plc's current P/E ratio is -8.2x. The historical average is 55.1x.
What is Amarin Corporation plc's ROE?
Amarin Corporation plc's return on equity (ROE) is -8.2%. The historical average is -57.2%.
Is AMRN stock overvalued?
Based on historical data, Amarin Corporation plc is trading at a P/E of -8.2x. Compare with industry peers and growth rates for a complete picture.
What are Amarin Corporation plc's profit margins?
Amarin Corporation plc has 56.6% gross margin and -6.5% operating margin.